The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is neoadjuvant chemoradiation important in borderline resectable pancreatic cancer (BRPC)? Clinical and surgical outcomes associated with preoperative FOLFIRINOX alone in BRPC.
 
Sunhee S. Kim
No Relationships to Disclose
 
Eric K. Nakakura
Consulting or Advisory Role - Ipsen
Research Funding - Lexicon
 
Zhen J. Wang
No Relationships to Disclose
 
Grace E. Kim
No Relationships to Disclose
 
Carlos U. Corvera
No Relationships to Disclose
 
Hobart W. Harris
No Relationships to Disclose
 
Kimberly S. Kirkwood
No Relationships to Disclose
 
Ryutaro Hirose
No Relationships to Disclose
 
Margaret A. Tempero
Consulting or Advisory Role - AstraZeneca; Asuragen; Bayer; Celgene; Myriad Genetics; Nucana; Pfizer; Portola Pharmaceuticals; Roche/Genentech
 
Andrew H. Ko
Consulting or Advisory Role - ARMO Biosciences; EMD Serono; Halozyme; Incyte; Merrimack
Research Funding - Acerta Pharma (Inst); Aduro Biotech (Inst); Celgene (Inst); ImClone Systems (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Merrimack (Inst); PharmaEngine (Inst); PRISM BioLab (Inst); Seagen (Inst)